Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK2 | O96017 | 1/20 | 0.34 |
| ▸ | PTPRF | P10586 | 8/20 | 0.33 |
| ▸ | PTPN2 | P17706 | 8/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 8/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CASP3 | P42574 | 1/20 | 0.32 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.32 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.32 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.32 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16452298 | 0.96 | CHEK2 (0.33) | CHEK2PTPRFPTPN2PTPN1KDM4E | |
| SCHEMBL14770562 | 0.95 | PTPRF (0.35) | CHEK2PTPRFPTPN2PTPN1KDM4E | |
| SCHEMBL14770691 | 0.94 | PLA2G2A (0.36) | PTPRFPTPN2PTPN1KDM4EKMT2A | |
| SCHEMBL14770611 | 0.94 | PLA2G2A (0.36) | PTPRFPTPN2PTPN1KDM4EKMT2A | |
| SCHEMBL14770637 | 0.93 | PTPRF (0.34) | CHEK2PTPRFPTPN2PTPN1KDM4E | |
| SCHEMBL19978773 | 0.93 | CHEK2 (0.32) | CHEK2PTPRFPTPN2PTPN1KDM4E | |
| SCHEMBL18158874 | 0.92 | KDM4E (0.39) | CHEK2PTPRFPTPN2PTPN1KDM4E | |
| SCHEMBL20708722 | 0.92 | CHEK2 (0.31) | CHEK2PTPRFPTPN2PTPN1 | |
| SCHEMBL14770625 | 0.92 | MKNK1 (0.33) | PTPRFPTPN2PTPN1MAPTKMT2A | |
| SCHEMBL14770617 | 0.92 | GABRP (0.32) | PTPRFPTPN2PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8895966-B2 | Material for organic electroluminescence element, and organic electroluminescence element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-11-25 | — | — | US | disclosed |
| US-8895966-B2 | Material for organic electroluminescence element, and organic electroluminescence element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-11-25 | — | — | US | disclosed |
| US-20130092905-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2013-04-18 | — | — | US | disclosed |
| US-20130092905-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2013-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130092905-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | LEF1, ORMDL3, CD99 | CHEK2 2848/4885PTPRF 1649/4885PTPN2 3761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.